Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2020 1
2021 2
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Interleukin-13 and its receptor are synaptic proteins involved in plasticity and neuroprotection.
Li S, Olde Heuvel F, Rehman R, Aousji O, Froehlich A, Li Z, Jark R, Zhang W, Conquest A, Woelfle S, Schoen M, O Meara CC, Reinhardt RL, Voehringer D, Kassubek J, Ludolph A, Huber-Lang M, Knöll B, Morganti-Kossmann MC, Brockmann MM, Boeckers T, Roselli F. Li S, et al. Among authors: woelfle s. Nat Commun. 2023 Jan 13;14(1):200. doi: 10.1038/s41467-023-35806-8. Nat Commun. 2023. PMID: 36639371 Free PMC article.
Shank2 identifies a subset of glycinergic neurons involved in altered nociception in an autism model.
Olde Heuvel F, Ouali Alami N, Aousji O, Pogatzki-Zahn E, Zahn PK, Wilhelm H, Deshpande D, Khatamsaz E, Catanese A, Woelfle S, Schön M, Jain S, Grabrucker S, Ludolph AC, Verpelli C, Michaelis J, Boeckers TM, Roselli F. Olde Heuvel F, et al. Among authors: woelfle s. Mol Autism. 2023 Jun 14;14(1):21. doi: 10.1186/s13229-023-00552-7. Mol Autism. 2023. PMID: 37316943 Free PMC article.
A phase II study of the PI3K inhibitor copanlisib in combination with the anti-CD20 monoclonal antibody rituximab for patients with marginal zone lymphoma: treatment rationale and protocol design of the COUP-1 trial.
Grunenberg A, Kaiser LM, Woelfle S, Schmelzle B, Viardot A, Möller P, Barth TFE, Muche R, Dreyhaupt J, Raderer M, Kiesewetter B, Buske C. Grunenberg A, et al. Among authors: woelfle s. BMC Cancer. 2021 Jun 29;21(1):749. doi: 10.1186/s12885-021-08464-6. BMC Cancer. 2021. PMID: 34187401 Free PMC article. Clinical Trial.